A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/519 (2006.01) A61K 9/16 (2006.01) A61K 9/24 (2006.01) A61K 9/32 (2006.01) A61K 9/36 (2006.01) A61K 9/48 (2006.01) A61K 31/616 (2006.01) A61P 7/02 (2006.01)
Patent
CA 2640472
The invention is directed to a dipyridamole formulation comprising an extended release formulation of dipyridamole and a pharmaceutically acceptable carboxylic acid, wherein the formulation is in a tablet solid form having a diameter of about 1.5 mm to about 3 mm. Optionally, the formulation may further comprise an immediate release acetylsalicylic acid formulation.
L'invention concerne une formulation de dipyridamole qui comprend une formulation à libération prolongée de dipyridamole et d'un acide carboxylique pharmaceutiquement acceptable, la formulation étant sous la forme d'un comprimé solide d'un diamètre d'environ 1,5 mm à environ 3 mm. Éventuellement, la formulation peut en outre comprendre une formulation d'acide acétylsalicylique à libération immédiate.
Fox Michael
Kanari Itamar
Leibovici Minutza
Heenan Blaikie Llp
Teva Pharmaceutical Industries Ltd.
LandOfFree
Dipyridamole extended-release formulations and process for... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Dipyridamole extended-release formulations and process for..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dipyridamole extended-release formulations and process for... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1475741